BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 4, 2007
View Archived Issues
Marshall Edwards recruiting patients in phase III trial of phenoxodiol
Read More
NeuralSTEM and University of Michigan to collaborate on stem cell R&D
Read More
GlaxoSmithKline receives European authorization for Arixtra in the treatment of ACS
Read More
Positive results for Accera's phase II study of Ketasyn for memory in older adults
Read More
New analgesic agents described in recent patent literature
Read More
Novel agents for neurological disorders reported in recent Proximagen and Janssen patents
Read More
Recent Merck & Co. patent imparts new treatment option for atherosclerosis
Read More
Modulation of mGlu5 receptor activity may provide benefit in incontinence and overactive bladder
Read More
Merck Serono applies to EMEA for extension of Erbitux indication in mCRC
Read More
Amgen describes new 11beta-HSD1 inhibitors with potential use in treating type 2 diabetes
Read More
Abbott and AstraZeneca to advance ABT-335 and Crestor combination
Read More
FDA extends Astellas Pharma US's Mycamine for injection sNDA three months
Read More
Wistar Institute's novel HIV vaccine receives funding for clinical trials
Read More
Improved antitumor activity and safety profile of nitric oxide derivative of pegylated epirubicin
Read More
Neuroprotective effects of coumaric acid derivative identified
Read More
Smallpox vaccine ACAM-2000 approved by FDA
Read More
Mylan begins offers for senior notes towards acquisition of Merck's generic pharmaceutical business
Read More
Meridian Bioscience begins parvovirus B19 vaccine phase I/II trials
Read More
ThromboGenics completes technology transfer to Bharat Biotech for THR-100
Read More
Positive interim results from Avexa's phase IIb trial of apricitabine for HIV
Read More
E-5555 inhibits thrombin-induced platelet aggregation in healthy volunteers
Read More
Extended release niacin/laropiprant demonstrates efficacy in dyslipidemia
Read More
Studies show improved lipids, no blood pressure increase with MK-0859
Read More